UMM logo

Joslin Diabetes Center

Clinical Trials We're Currently Enrolling Patients For

Doctor is asking questions

Clinical trials are studies designed to find new and better ways to treat patients with diabetes. The physicians at the University of Maryland Joslin Diabetes Center are currently conducting the clinical trials listed below.

For more information on any of these clinical trials, or to inquire about participating, call: 410-328-7254 or 1-888-JOSLIN8 (1-888-567-5468)

 

1. Clinical Trial Detail - Genetics of Pancreatic Function

Official Title:

Genetics of Pancreatic Function in the Development of Diabetes

Purpose:

Find out whether some people are more likely to get diabetes than others by studying their genes.

Investigator(s):

Kristi Silver, M.D.

Requirements:

Sampling of blood sample (fingerstick) to determine genotype
Between ages of 18 & 45 years
Generally good health

Participation:

The first part of the study involves one brief (15 minute) visit to collect a blood sample for genotyping. The second part of the study involves 2 separate visits, the first lasting approximately 4 hours and the second lasting approximately 6 hours. During the second part of the study, volunteers will undergo a test for diabetes (2 hour test), measurements of body fat via X-ray, and measurements of insulin production by the pancreas. Financial compensation provided for time.

Contact:

Dr. Silver 410-706-1628

2. Clinical Trial Detail - Pharmacogenetics of Pro12Ala PPAR-gamma-2

Official Title:

Pharmacogenetics of Pro12Ala PPAR-gamma-2

Purpose:

To study individual response to glucose-lowering medicine in people who have pre-diabetes development.

Investigator(s):

Alan Shuldiner, M.D.

Requirements:

Sampling of blood sample (fingerstick) to determine genotype

Between ages of 35 & 70 years

Participation:

Three-month treatment with diabetes medicine (avandia), followed by 12-week weight-loss program. Four to six visits in initial three-month treatment. Weekly visits for weight-loss program. Financial compensation provided for time.

Contact:

Soren Snitker MD, PhD 410-706-1511

3. Clinical Trial Detail - GDO

Official Title:

Genetics of Diabetes and Obesity

Purpose:

Study genes that may contribute to the development of diabetes and obesity.

Investigator(s):

Alan Shuldiner, M.D., Kristi Silver, M.D.

Requirements:

Participants can include ANYONE (those with diabetes, those without diabetes, those who are overweight, those who do not have weight problems).

Participation:

One brief visit to collect blood sample and complete a short questionnaire. Through participation in this study, a person may qualify for other studies that research particular genotypes.

Contact:

Dr. Silver 410-706-1628

4. Clinical Trial Detail - BARI 2D

Official Title:

Bypass Angioplasty Revascularization Investigation 2 Diabetes

Purpose:

Study cardiovascular disease in type 2 diabetes. Aggressive management of identified cardiovascular disease and diabetes by a collaborative team consisting of cardiologists, endocrinologists, nurses, nutritionists, and exercise physiologist.

Investigator(s):

Tom Donner, M.D., Liz Streeten, M.D.

Requirements:

A positive stress test or angina symptoms that require evaluation by cardiac catheterization.

  • Type 2 diabetes
  • Age >25 years
  • HbA1c <13%
  • Participation:

    5 year study. Some medications (FDA approved) available thru the study. Glucose monitor and strips now available.

    Contact:

    Dr. Donner at 410-328-6542 or Dana, RN, at 410-328-1045.

    back to top

    Pediatric Clinical Trials

    5. Epidemiology of Diabetes Interventions and Complications

    Official Title:

    Epidemiology of Diabetes Interventions and Complications

    Purpose:

    To study diabetes complications in people with Type 1 diabetes who participated in the Diabetes Complications and Control Trial to assess long term effects of intensive management.

    Investigator(s):

    Matthew Hebdon, M.D., Debra Counts, M.D., Thomas Donner, M.D.

    Requirements:

    Participant in DCCT

    Contact:

    Sherry 410-328-3411

    6. TrialNet

    Official Title:

    TrialNet

    Purpose:

    To screen siblings, parents, and children of people with Type 1 diabetes for diabetes risk, and to develop methods to prevent Type 1 diabetes.

    Investigator(s):

    Debra Counts, M.D.

    Requirements:

    Age 4 - 45
    Relative of someone with Type 1 diabetes

    Contact:

    Mary 410-328-5419

    7. Preservation of Insulin-Producing Cells in Children with New Onset Type 1 Diabetes

    Official Title:

    Preservation of insulin-producing cells in children with new onset Type 1 diabetes.

    Purpose:

    To test a special diet in children newly diagnosed with Type 1 diabetes to see if the remaining insulin-producing ability can be preserved.

    Investigator(s):

    Debra Counts, M.D.

    Requirements:

    Age < 18 years
    Type 1 Diabetes diagnosed < 6 weeks ago

    Contact:

    Mary 410-328-5419 or Dr. Counts 410-328-3412

    back to top


    This page was last updated on: August 21, 2007.

    For appointments or information, call 1-888-JOSLIN8 (1-888-567-5468).